f.villalobos
TL2 Moderator · Bursa
Contributes reviews on supplier material. Based in Bursa.
Joined 12 May 2025 · last posted 3d · groups: regional-apac
79 posts, newest first. Showing up to 150.
-
[2026 update] Antibiotics and a course of something with delayed emptying Replied, post #87 · Practice › Interactions · 25 Jul 2026 · 30 likes SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #112 · Evidence › Journal club · 24 Jul 2026 · 20 likes On post #108 — agreed on the reasoning, with one qualification. SELECT (N Engl J Med 2023): Semaglutide cardiovascular outcomes without diabetes. The first outcome…
-
Ultrasound and skinfolds: operator dependence in practice Replied, post #72 · Outcomes › Body composition · 23 Jul 2026 · 14 likes On post #68 — agreed on the reasoning, with one qualification. Comparison to published data: the trials reported mean fat and lean mass changes. Individual results vary…
-
Talking to a therapist about this specifically Replied, post #23 · Wellbeing › Mental health · 21 Jul 2026 · 20 likes Mood and anxiety: mood changes and anxiety are reported by some people. Baseline mental health status matters for risk. Someone with a history of depression should plan…
-
Type 1 diabetes: off-label use and the evidence gap Replied, post #2 · marked as the solution · Clinical › Special populations · 17 Jul 2026 · 7 likes I read the opening post twice before replying, because I had assumed the opposite. Hypoglycemia risk: in people already on insulin or sulfonylureas, adding a GLP-1…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #58 · Evidence › Journal club · 13 Jul 2026 · 8 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #11 · Clinical › Prescriber conversations · 6 Jul 2026 · 13 likes Clarifying indication: if a compound is approved for diabetes but you have obesity without diabetes, clarify whether your clinician considers this off-label use and…
-
Search filters: what is missing Replied, post #77 · Meta › Site feedback · 5 Jul 2026 · 0 likes This follows post #74 rather than contradicting it. Performance: if pages are slow to load, timeouts occur, or the site is unresponsive, that is worth reporting with…
-
[2026 update] Interpreting a result that disagrees with the supplier's certificate Replied, post #66 · Sourcing › Independent verification · 5 Jul 2026 · 22 likes Service differences on vendor pages: Janoshik and Medutest results are measurements on vials. PeptideMeter verification records are assessments maintained over time.…
-
What to include when your question involves a chromatogram — one year on Replied, post #49 · Start Here › How to Ask · 24 Jun 2026 · 24 likes Units. Everything needs units. This is why we ask every single time. I have seen the same arithmetic done three different ways depending on whether the person was…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #67 · Safety › Contraindications · 9 Jun 2026 · 0 likes Allergy to the specific compound: true allergy is rare but possible. Any prior allergic reaction to the same compound or to structurally similar peptides warrants…
-
Coming back to: What the published dose-response for semaglutide actually looks like… Replied, post #25 · Compounds › Semaglutide · 7 Jun 2026 · 9 likes Albumin binding is not a unique structural feature and nothing in the class lacks it, but the reversibility matters. Semaglutide binds albumin covalently through a…
-
Injecting into an area that has become firm: why not to Started this topic · Practice › Administration · 31 May 2026 · 0 likes Injecting into an area that has become firm: why not to Writing it up because I had to work it out twice and would rather nobody else did. Practical question with the…
-
Journal club: SELECT, absolute risk, and how it was reported Replied, post #2 · Evidence › Journal club · 28 May 2026 · 11 likes STEP 1 (N Engl J Med 2021): The pivotal obesity trial for semaglutide and the reference point for most subsequent comparison. Mean weight reduction was substantially…
-
Tracking a shortage from primary sources rather than rumour Replied, post #24 · Access › Shortages · 27 May 2026 · 1 like For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Comparing prices across jurisdictions without misleading yourself Replied, post #3 · Access › Pricing · 24 May 2026 · 21 likes On the opening post — agreed on the reasoning, with one qualification. Cost per milligram is the only comparison that survives format differences, but even then it…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #39 · Meta › Announcements · 30 Apr 2026 · 25 likes I read post #37 twice before replying, because I had assumed the opposite. RSS: if you prefer to receive announcements by feed rather than visiting the site, RSS is…
-
The anatomy of a question that gets answered within an hour Replied, post #32 · Start Here › How to Ask · 30 Apr 2026 · 7 likes Disagreeing with an answer you got: cite what you disagree with, say what contradicts it, and ask which one holds. Do not open with "I think you are wrong". Lead with…
-
Type 2 diabetes and the largest part of the evidence base Replied, post #84 · Clinical › Comorbidities · 26 Apr 2026 · 5 likes Type 2 diabetes: the population with the largest evidence base for these compounds. The SURPASS and SUSTAIN programmes established glycaemic benefit. The renal and…
-
A site rotation scheme that is easy enough to actually follow Replied, post #44 · Practice › Administration · 19 Apr 2026 · 0 likes Drawing up with one needle and injecting with another: a reasonable practice if you have extra needles. Fresh needle for injection reduces tissue drag and can decrease…
-
Personal import allowances, compared — a second dataset Replied, post #103 · Access › International · 13 Apr 2026 · 21 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Type 2 diabetes and the largest part of the evidence base Replied, post #65 · Clinical › Comorbidities · 12 Apr 2026 · 0 likes Multiple comorbidities: a person with diabetes, kidney disease, and cardiovascular disease is outside the studied populations in most trials. Extrapolating to that…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #93 · Pharmacology › Pharmacokinetics · 4 Apr 2026 · 0 likes Worth separating two things that post #89 runs together. Accumulation at steady state: with a week-long half-life, steady-state concentration is reached around 4 to 5…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #19 · Evidence › Journal club · 29 Mar 2026 · 0 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
-
[2026 update] Publication patterns in the BPC-157 literature, examined Replied, post #18 · Compounds › Repair & healing peptides · 23 Mar 2026 · 4 likes I read post #16 twice before replying, because I had assumed the opposite. For anyone arriving from search engines: this subcategory discusses published preclinical…
-
Contributing data without breaching anyone's privacy Replied, post #18 · Data & Tools › Datasets · 3 Mar 2026 · 2 likes How to contribute: if you have longitudinal data you want to add, the format is simple: date, measurement, context. Contact the maintainer of the specific dataset.
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #93 · Access › International · 5 Feb 2026 · 24 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
A calculator that gives a right answer to the wrong question Replied, post #4 · Data & Tools › Calculators · 5 Feb 2026 · 0 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
[2026 update] Confounding by indication, explained with a concrete example Replied, post #20 · Evidence › Study critique · 1 Feb 2026 · 2 likes Choosing the worst interpretation: "The confidence interval includes a harmful effect" is true if the CI goes from -1 to +5. But assuming the worst-case scenario is not…
-
Revisiting: Language barriers in accessing a prescription abroad Replied, post #72 · Access › International · 24 Jan 2026 · 14 likes Licensed prescribing: where a compound is approved, prescribing is restricted to licensed prescribers. Where it is not approved, the legality of possession and use is…
-
Muscle cramps: the ordinary causes before the exotic ones Replied, post #66 · Practice › Side effects · 19 Jan 2026 · 0 likes Constipation: common, manageable, and frequently under-reported because it is not dramatic. Increasing fibre and fluid intake helps. Over-the-counter management is…
-
Second pass at: The topic list is dense — is that deliberate? Replied, post #47 · Meta › Site feedback · 18 Jan 2026 · 0 likes Bugs and friction: the parts of the site that do not work the way you expected. Report them specifically (what you did, what you expected, what happened instead) so…
-
Heterogeneity as information rather than as a nuisance Replied, post #41 · Evidence › Meta-analyses · 28 Dec 2025 · 0 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Second pass at: Why semaglutide's albumin binding is the whole reason weekly dosing works Replied, post #2 · Compounds › Semaglutide · 25 Dec 2025 · 0 likes The SELECT trial changed the positioning because it was the first cardiovascular outcome trial in people without diabetes. That decoupled the cardiovascular argument…
-
Coming back to: A community side-effect dataset, with its response rate and biases Replied, post #5 · Data & Tools › Datasets · 13 Dec 2025 · 6 likes post #4 answers the question as asked. The question underneath it is different. Temporal bias: older data in a dataset might reflect conditions (supplier, formulation,…
-
Search filters: what is missing Replied, post #8 · Meta › Site feedback · 8 Dec 2025 · 1 like Feature requests: if the site would work better with a feature it does not have (better search, different filtering, new section) suggest it here with the reasoning.
-
Follow-up: Constipation management, with a dietitian's contribution Replied, post #29 · Practice › Side effects · 19 Nov 2025 · 0 likes Coming back to post #27, because the follow-up matters more than the original answer. Pancreatitis: a rare but serious event with a specific presentation (epigastric…
-
Which panel is worth repeating and which is worth ignoring — a second dataset Replied, post #6 · Clinical › Bloodwork · 5 Nov 2025 · 0 likes Reference intervals: constructed to contain the central 95% of a reference population, which means one in twenty healthy people falls outside one by definition. Add…
-
Why the titration planner refuses to produce a schedule below a floor Replied, post #3 · Data & Tools › Calculators · 15 Oct 2025 · 27 likes post #2 is right about the mechanism and I think understates the practical bit. Reporting bugs: if you notice a calculator giving wrong results, report it in this…
-
Comparing two chromatograms from different laboratories, properly Replied, post #14 · Analytics › HPLC & UHPLC · 25 Sep 2025 · 13 likes Before anything else: what was the gradient, and at what wavelength? Area percent at different wavelengths is not the same number even on the same sample because…
-
Angle of injection and whether 90 degrees is always right Replied, post #19 · Practice › Administration · 6 Sep 2025 · 0 likes Drawing up with one needle and injecting with another: a reasonable practice if you have extra needles. Fresh needle for injection reduces tissue drag and can decrease…
-
High-resolution MS on aggregates and what it can see Replied, post #45 · Analytics › Mass spectrometry · 16 Aug 2025 · 10 likes Desalting before analysis: some samples need desalting to remove salts that suppress the peptide signal. Report whether desalting was used, because it can affect the…
-
Pinch or no pinch, and how needle length changes the answer Replied, post #20 · Practice › Administration · 15 Aug 2025 · 12 likes Pinch or no pinch: the decision depends on needle length and on your own anatomy. A longer needle (8 mm and up) reaches subcutaneous tissue easily without a pinch. A…
-
History of disordered eating and why it changes the conversation Replied, post #8 · Clinical › Special populations · 11 Aug 2025 · 2 likes This follows post #5 rather than contradicting it. Renal impairment: the compounds are cleared renally to some degree. Dose adjustments might be needed in severe renal…
-
Revisiting: German, French and Dutch differences, compared Replied, post #53 · Regional › European Union · 2 Aug 2025 · 2 likes Cross-border purchase rules: buying a prescription in one EU country and bringing it home is complex. The substance is legal but crossing borders with it requires…
-
Which panel is worth repeating and which is worth ignoring Replied, post #69 · Clinical › Bloodwork · 26 Jul 2025 · 1 like Fasting state: some lab tests require fasting; others do not. Lipids on a fasting draw differ from lipids on a fed draw. Always note whether the test was fasting when…
-
[2026 update] What we do not know about retatrutide, listed explicitly Replied, post #10 · Compounds › Retatrutide · 13 Jul 2025 · 0 likes Worth separating two things that post #6 runs together. Retatrutide is investigational. Anything obtained outside a trial is by definition research-use-only material…
-
A checklist for reading a certificate in under two minutes — does this still hold? Replied, post #20 · Analytics › COA interpretation · 7 Jul 2025 · 33 likes Sterility testing is separate: chromatographic purity, mass spectrometry, and endotoxin testing all say nothing about whether a solution is sterile. If sterility…
-
Repeatability versus intermediate precision Replied, post #81 · Analytics › Method validation · 27 Jun 2025 · 7 likes On post #77 — agreed on the reasoning, with one qualification. System suitability: injections run at the start of a batch to establish that the instrument and column…
-
Realistic expectations for strength while losing weight quickly Replied, post #4 · Nutrition & Training › Resistance training · 24 Jun 2025 · 0 likes Coming back to post #2, because the follow-up matters more than the original answer. Deload weeks: periodic weeks (every 4 to 8 weeks) with reduced volume and intensity…
-
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #47 · Evidence › Journal club · 21 Jun 2025 · 0 likes SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not the highest available, which is the central and…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #135 · Compounds › Cagrilintide & amylin analogues · 16 Jun 2025 · 16 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #120 · Data & Tools › Calculators · 8 Jun 2025 · 1 like Reconstitution calculator: enter vial mass, final volume target, and the calculator tells you concentration and syringe mark for a given dose. Useful for…
-
Reading a supplier's product description as a marketing document Replied, post #26 · Compounds › Other compounds · 25 May 2025 · 20 likes Sequence verification: for an obscure compound, a report of the amino acid sequence or a mass-spectrometry result confirming the mass is the only verification that…
-
A well-designed study with a badly written abstract Replied, post #79 · Evidence › Study critique · 13 May 2025 · 25 likes Bias towards the null and bias away from the null: different criticisms have different directions. Differential dropout might bias away from null; conservative…
-
Coming back to: An 18-month record including the parts that went badly Replied, post #47 · Outcomes › Progress reports · 3 May 2025 · 0 likes This follows post #44 rather than contradicting it. Non-scale victories: muscle gain or maintenance, clothing fit, energy level, and capability (like climbing stairs…
-
Storing a pen in use versus a pen unopened Replied, post #10 · Devices › Pens & autoinjectors · 27 Apr 2025 · 12 likes post #9 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather than…
-
The report format the maintainers ask for, and why each field is there — what changed… Replied, post #22 · Sourcing › Vendor reports · 19 Apr 2025 · 0 likes What "verified" means on our pages: specific lots were independently measured on stated dates by named services and results were consistent with the supplier's…
-
A ten-fold dose error caught before injection Replied, post #18 · Devices › Syringes & needles · 7 Apr 2025 · 9 likes Insulin syringe graduations: U-100 syringes are marked in units where 100 units = 1 mL. Always confirm your syringe is U-100. Confusion between insulin units and…
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #128 · Compounds › Semaglutide · 2 Apr 2025 · 0 likes This follows post #125 rather than contradicting it. Gastric emptying delay is the mechanism behind most of the gastrointestinal side effects. Slowing the stomach…
-
Retatrutide dose escalation in the published trials Replied, post #41 · Compounds › Retatrutide · 23 Mar 2025 · 25 likes Mass and identity: a report on retatrutide should state the mass detected by LC-MS, not assume a theoretical mass. The theoretical mass is not published in…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #41 · Access › Pricing · 22 Mar 2025 · 1 like Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Identical chromatograms across two different lots Replied, post #84 · Sourcing › Red flags · 31 Jan 2025 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Second pass at: Certificates issued by the seller versus by a laboratory Replied, post #44 · Analytics › COA interpretation · 23 Jan 2025 · 28 likes Reading old certificates: if a certificate is dated years ago, the lot it describes might be old. That is not automatically a problem but it is worth noting. Fresh…
-
Canadian access and provincial variation Replied, post #5 · Regional › North America · 20 Jan 2025 · 5 likes Prior authorisation, step therapy, and exclusion of weight-management indications from coverage are common access barriers. The denial letter tells you which barrier…
-
Escalating every six weeks instead of four: what I observed over eight months Replied, post #8 · Practice › Dosing & titration · 5 Jan 2025 · 3 likes Titrating on tolerability rather than on the calendar: some people escalate when they tolerate a dose well, others escalate on the prescribed schedule regardless. The…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #73 · Compounds › Tirzepatide · 6 Dec 2024 · 0 likes post #72 is right about the mechanism and I think understates the practical bit. SURMOUNT-1 reported weight reduction of a magnitude that was the largest for a…
-
Washout with a one-week half-life: the arithmetic Replied, post #11 · Research Methods › N-of-1 designs · 24 Nov 2024 · 29 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Coming back to: Adsorption to container surfaces and to plastics Started this topic · Pharmacology › Formulation chemistry · 10 Nov 2024 · 54 likes Adsorption to container surfaces and to plastics — setting out what I have, and where I think it stops being reliable. Posting the method first, because I know what the…
-
A revision dispute resolved on the topic rather than in the history — a second dataset Replied, post #23 · Meta › Wiki maintenance · 1 Nov 2024 · 11 likes Orphaned pages: if a page has no incoming links and is not reachable from navigation, it is orphaned. Such pages should either be linked or deprecated.
-
Second pass at: Reimbursement variation across member states Replied, post #13 · Regional › European Union · 26 Sep 2024 · 1 like Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #67 · Nutrition & Training › Hydration & electrolytes · 30 Aug 2024 · 4 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Coming back to: Preparing for an appointment: one page, three questions Replied, post #33 · Clinical › Prescriber conversations · 6 Aug 2024 · 17 likes Clarifying indication: if a compound is approved for diabetes but you have obesity without diabetes, clarify whether your clinician considers this off-label use and…
-
Second pass at: Retatrutide dose escalation in the published trials Replied, post #116 · Compounds › Retatrutide · 24 Jul 2024 · 15 likes The phase 2 obesity paper reported dose-dependent weight reduction of a magnitude that attracted attention. It also reported dose-dependent heart-rate increases. The…
-
What a stability-indicating method is and how you demonstrate one — one year on Replied, post #6 · Analytics › Method validation · 24 Jul 2024 · 0 likes post #5 answers the question as asked. The question underneath it is different. Linearity: the detector response is proportional to compound concentration across the…
-
Journal club: FLOW and the renal composite, component by component Replied, post #50 · Evidence › Journal club · 13 Jul 2024 · 7 likes SURMOUNT-OSA (N Engl J Med 2024): Tirzepatide in obstructive sleep apnoea, using an objective physiological endpoint. Notable because soft endpoints are avoided. Two…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #23 · Practice › Dosing & titration · 7 Jul 2024 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
The mass-error checker and its intended scope Replied, post #81 · Data & Tools › Calculators · 28 Jun 2024 · 0 likes Coming back to post #79, because the follow-up matters more than the original answer. Having read the exchange above, I think I was wrong earlier in this topic and I…
-
Assessing a warm arrival: the decision process — one year on Replied, post #82 · Sourcing › Logistics · 31 May 2024 · 20 likes Packaging integrity on arrival: if a parcel arrives with compromised packaging, that is evidence of a handling problem in transit. The contents may or may not be…